McKee E E, Bentley A T, Smith R M, Kraas J R, Ciaccio C E
South Bend Center for Medical Education, Indiana University School of Medicine, University of Notre Dame, Notre Dame, Indiana 46556, USA.
Am J Physiol Cell Physiol. 2000 Dec;279(6):C1870-9. doi: 10.1152/ajpcell.2000.279.6.C1870.
In previous work (McKee EE, Bentley AT, Smith RM Jr, and Ciaccio CE, Biochem Biophys Res Commun 257: 466-472, 1999), the transport of guanine nucleotides into the matrix of intact isolated heart mitochondria was demonstrated. In this study, the time course and mechanisms of guanine nucleotide transport are characterized. Two distinct mechanisms of transport were found to be capable of moving guanine nucleotides across the inner membrane. The first carrier was saturable, displayed temperature dependence, preferred GDP to GTP, and did not transport GMP or IMP. When incubated in the absence of exogenous ATP, this carrier had a V(max) of 946 +/- 53 pmol. mg(-1). min(-1) with a K(m) of 2.9 +/- 0.3 mM for GDP. However, transport of GTP and GDP on this carrier was completely inhibited by physiological concentrations of ATP, suggesting that this carrier was not involved with guanine nucleotide transport in vivo. Because transport on this carrier was also inhibited by atractyloside, this carrier was consistent with the well-characterized ATP/ADP translocase. The second mechanism of guanine nucleotide uptake was insensitive to atractyloside, displayed temperature dependence, and was capable of transporting GMP, GDP, and GTP at approximately equal rates but did not transport IMP, guanine, or guanosine. GTP transport via this mechanism was slow, with a V(max) of 48.7 +/- 1.4 pmol. mg(-1). min(-1) and a K(m) = 4.4 +/- 0.4 mM. However, because the requirement for guanine nucleotide transport is low in nondividing tissues such as the heart, this transport process is nevertheless sufficient to account for the matrix uptake of guanine nucleotides and may represent the physiological mechanism of transport.
在之前的研究工作中(麦基EE、本特利AT、小史密斯RM和恰乔CE,《生物化学与生物物理研究通讯》257: 466 - 472,1999年),已证实鸟嘌呤核苷酸可转运至完整分离的心脏线粒体基质中。在本研究中,对鸟嘌呤核苷酸转运的时间进程和机制进行了表征。发现有两种不同的转运机制能够使鸟嘌呤核苷酸穿过内膜。第一种载体具有饱和性,表现出温度依赖性,相较于GTP更偏好GDP,且不转运GMP或IMP。在无外源ATP的情况下孵育时,该载体对GDP的V(max)为946 ± 53 pmol·mg⁻¹·min⁻¹,K(m)为2.9 ± 0.3 mM。然而,生理浓度的ATP可完全抑制该载体对GTP和GDP的转运,这表明该载体在体内不参与鸟嘌呤核苷酸的转运。由于该载体的转运也受到苍术苷的抑制,所以此载体与已充分表征的ATP/ADP转位酶一致。鸟嘌呤核苷酸摄取的第二种机制对苍术苷不敏感,表现出温度依赖性,能够以大致相同的速率转运GMP、GDP和GTP,但不转运IMP、鸟嘌呤或鸟苷。通过这种机制的GTP转运较慢,V(max)为48.7 ± 1.4 pmol·mg⁻¹·min⁻¹,K(m) = 4.4 ± 0.4 mM。然而,由于在心脏等非分裂组织中对鸟嘌呤核苷酸转运的需求较低,所以这种转运过程仍足以解释鸟嘌呤核苷酸的基质摄取,并且可能代表了生理转运机制。